Odyssey Therapeutics, Inc. (ODTX)
19.00
+0.88
(+4.86%)
USD |
NASDAQ |
Oct 09, 16:00
18.92
-0.08
(-0.42%)
After-Hours: 20:00
Odyssey Therapeutics Market Cap : 909.93M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 909.93M |
| October 08, 2026 | 867.79M |
| October 07, 2026 | 865.87M |
| October 06, 2026 | 868.27M |
| October 05, 2026 | 998.05M |
| October 02, 2026 | 992.55M |
| October 01, 2026 | 977.94M |
| September 30, 2026 | 1.064B |
| September 29, 2026 | 1.075B |
| September 28, 2026 | 1.028B |
| September 25, 2026 | 982.25M |
| September 24, 2026 | 954.47M |
| September 23, 2026 | 994.22M |
| September 22, 2026 | 1.118B |
| September 21, 2026 | 1.104B |
| September 18, 2026 | 1.168B |
| September 17, 2026 | 1.112B |
| September 16, 2026 | 1.107B |
| September 15, 2026 | 1.053B |
| September 14, 2026 | 1.162B |
| September 11, 2026 | 1.180B |
| September 10, 2026 | 1.132B |
| September 09, 2026 | 1.174B |
| September 08, 2026 | 1.292B |
| September 04, 2026 | 1.377B |
| Date | Value |
|---|---|
| September 03, 2026 | 1.264B |
| September 02, 2026 | 1.275B |
| September 01, 2026 | 1.173B |
| August 31, 2026 | 1.174B |
| August 28, 2026 | 1.167B |
| August 27, 2026 | 1.244B |
| August 26, 2026 | 1.227B |
| August 25, 2026 | 1.256B |
| August 24, 2026 | 1.204B |
| August 21, 2026 | 1.264B |
| August 20, 2026 | 1.181B |
| August 19, 2026 | 1.161B |
| August 18, 2026 | 1.051B |
| August 17, 2026 | 999.01M |
| August 14, 2026 | 992.79M |
| August 13, 2026 | 992.31M |
| August 12, 2026 | 1.033B |
| August 11, 2026 | 974.59M |
| August 10, 2026 | 1.062B |
| August 07, 2026 | 1.014B |
| August 06, 2026 | 1.032B |
| August 05, 2026 | 1.000B |
| August 04, 2026 | 955.91M |
| August 03, 2026 | 870.81M |
| July 31, 2026 | 909.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
| Vericel Corp. | 2.052B |
Market Cap Related Metrics
| PS Ratio | 316.97 |
| PEG Ratio | -0.0389 |
| Price to Book Value | 2.160 |
| Price | 19.00 |
| Earnings Yield | -18.72% |
| PEGY Ratio | -0.0389 |